Company Filing History:
Years Active: 2009
Title: The Innovations of Daniel E. Gottschling
Introduction
Daniel E. Gottschling is an accomplished inventor based in Seattle, WA. He is known for his significant contributions to the field of cancer research. His innovative work focuses on methods that can potentially lead to breakthroughs in cancer treatment.
Latest Patents
One of his notable patents is titled "Methods for inhibiting deacetylase activity." This patent discloses a method for identifying a compound that inhibits the NAD-dependent deacetylase activity of a SIR2 protein. The compounds identified through this method are useful for treating cancers and other diseases. They work by activating silenced genes, promoting apoptosis in cancerous cells, and inhibiting transcriptional repressor activity in oncogenes. Daniel E. Gottschling holds 1 patent.
Career Highlights
Daniel E. Gottschling is affiliated with the Fred Hutchinson Cancer Center, where he conducts his research. His work at this prestigious institution has positioned him as a key figure in the fight against cancer. His innovative approaches have the potential to change the landscape of cancer treatment.
Collaborations
He has collaborated with notable colleagues such as Antonio Bedalov and Julian Simon. These collaborations have further enriched his research and contributed to the advancement of cancer therapies.
Conclusion
Daniel E. Gottschling's work exemplifies the spirit of innovation in the field of cancer research. His contributions through patents and collaborations highlight the importance of scientific advancements in improving treatment options for patients.